Insights On Trial Design

1. Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule 1/22/2026

   Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.

2. Opportunities For Enhancing Signal Detection In Schizophrenia Trials 9/18/2024

   Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.

3. Antibody-Drug Conjugates: 'Magic Bullets' Become Reality 2/19/2025

   Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.

4. 4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials 5/9/2025

   Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

5. Travel And Payment Services: A Patient's Journey 12/5/2025

   Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.

6. Delving Into The Current Global Landscape Of Gastric Cancer Clinical Trials 9/17/2024

   Gain insights into the evolving landscape of gastric cancer care and examine significant advancements and ongoing challenges in the fight against this formidable disease.

7. Patient Diversity: Identifying Challenges, Opportunities, And Best Practices 4/10/2024

   By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.

8. Multi-Regional Clinical Trials: The Latest Guidance From FDA 3/12/2025

   Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.

9. Streamlining Phase 1 Trials With The Mobile Vision Pod 1/29/2025

   A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.

10. Enhancing ER Patient Recruitment 6/26/2024

    Scout's custom information delivery mechanism for clear, accessible patient education facilitated trial enrollment in a high-pressure emergency room setting.